Gislei Frota Aragão

Gislei Frota Aragão

Auto-generated profile, based on publicly available information

Gislei Frota Aragão

Superior Institute of Biomedical Sciences, Ceará State University, Fortaleza, Brazil

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2018 in Fundamental & Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
ANAmaurilio O. Nogueira
Amaurilio O. Nogueira
YOYasmin Ingrid S. Oliveira
Yasmin Ingrid S. Oliveira
BABeatriz L. Adjafre
Beatriz L. Adjafre
MMMaria E. Amaral de Moraes
Maria E. Amaral de Moraes
GAGislei F. Aragão
Gislei F. Aragão
Protium heptaphyllum Aubl. belongs to the Burseraceae family. It is commonly called ‘almecegueira’ and is known to produce an amorphous resin which has constituents such as α‐ and β‐amyrin, taraxastan‐3‐oxo‐20‐ol and sitostenonein. The α‐ and β‐amyrin from P. heptaphyllum have pharmacological activities in several systems, such as central and peripheral nervous system, gastrointestinal tract and immunological system. In this study, our objective was to review pharmacological activities and to gather more information on the mixture of α‐ and β‐amyrin obtained from P. heptaphyllum to guide future preclinical and clinical studies using this compound. This review consisted of searches performed using scientific databases such as PubMed, SciELO, LILACS, SciFinder and Science Direct. Some uses of α‐ and β‐amyrin have been partially confirmed by previous studies demonstrating analgesic, anti‐inflammatory, anticonvulsant, antidepressive, gastroprotective, hepatoprotective, antipancreatitic, anticholytic, antihyperglycemic and hypolipidemic effects. It is noteworthy that there are no α‐ and β‐amirin toxicity tests described in the literature as recommended in the international guidelines, and such tests are one of the research stages to proceed in clinical and preclinical trials if this compound was to be used.

1 February 2021 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
GCG.T. Costa
G.T. Costa
QVQ.D.J.S. Vasconcelos
Q.D.J.S. Vasconcelos
GAG.C. Abreu
G.C. Abreu
AAA.O. Albuquerque
A.O. Albuquerque
JVJ.L. Vilar
J.L. Vilar
GAG.F. Aragão
G.F. Aragão

30 May 2020 in Medical Hypotheses
Verified
Journal Article
Closed access
MLMatheus Eugênio de Sousa Lima
Matheus Eugênio de Sousa Lima
LBLevi Coelho Maia Barros
Levi Coelho Maia Barros
GAGislei Frota Aragão
Gislei Frota Aragão

1 April 2020 in Archives de Pédiatrie
Verified
Journal Article
Closed access
GCG. Costa
G. Costa
QVQ. Vasconcelos
Q. Vasconcelos
GAG. Abreu
G. Abreu
AAA. Albuquerque
A. Albuquerque
JVJ. Vilarejo
J. Vilarejo
GAG. Aragão
G. Aragão


18 December 2022 in Birth Defects Research
Verified
Journal Article
Closed access
CCCarla Larissa de Castro Vieira Carneiro
Carla Larissa de Castro Vieira Carneiro
ECEdna Maria Camelo Chaves
Edna Maria Camelo Chaves
KNKelly Rose Tavares Neves
Kelly Rose Tavares Neves
MBMarcus Davis Machado Braga
Marcus Davis Machado Braga
AAAna Maria Sampaio Assreuy
Ana Maria Sampaio Assreuy
GAGislei Frota Aragão
Gislei Frota Aragão